Influence of sample collection and storage on the detection of platelet factor 4-heparin antibodies

American Journal of Clinical Pathology

Volumn 128, Issue 1, 2007, Pages 150-155

  Krakow, Elizabeth F ^a   Goudar, Ranjit ^a   Petzold, Elizabeth ^a   Suvarna, Shayela ^a   Last, Michael ^a   Welsby, Ian J ^a   Ortel, Thomas L ^a   Arepally, Gowthami M ^a,b  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b DUKE UNIVERSITY HEALTH SYSTEM   (United States)

Author keywords

Enzyme linked immunosorbent assay; Heparin; Heparin induced thrombocytopenia; Platelet factor 4

Indexed keywords

CITRATE SODIUM; EDETIC ACID; HEPARIN; THROMBOCYTE FACTOR 4; ANTIBODY;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; BLOOD SMEAR; BLOOD STORAGE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; ENZYME LINKED IMMUNOSORBENT ASSAY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; HUMAN CELL; IMMUNOASSAY; PRIORITY JOURNAL; THROMBOCYTOPENIA; BLOOD; IMMUNOLOGY; METHODOLOGY;

ANTIBODIES; BLOOD SPECIMEN COLLECTION; EDETIC ACID; HEPARIN; HUMANS; PLATELET FACTOR 4;

EID: 34547103002     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/RFQK57F5QMURQ1HY     Document Type: Article

References (20)

1. Warkentin TE, Greinacher A. Heparin-induced thrombocytopenia: recognition, treatment, and prevention: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy [published correction appears in Chest. 2005;127:416]. Chest. 2004;126(3 suppl):311S-337S.
2. Warkentin TE, Sheppard J-AI, Moore JC, et al. Laboratory testing for the antibodies that cause heparin-induced thrombocytopenia: how much class do we need? J Lab Clin Med. 2005;146:341-346.
3. Bauer TL, Arepally G, Konkle BA, et al. Prevalence of heparin-associated antibodies without thrombosis in patients undergoing cardiopulmonary bypass surgery. Circulation. 1997;95:1242-1246.
4. Trossaert M, Gaillard A, Commin PL, et al. High incidence of anti-heparin/platelet factor 4 antibodies after cardiopulmonary bypass surgery. Br J Haematol. 1998;101:653-655.
5. Warkentin TE, Sheppard JA, Horsewood P, et al. Impact of the patient population on the risk for heparin-induced thrombocytopenia. Blood. 2000;96:1703-1708.
6. Alberio L, Kimmerle S, Baumann A, et al. Rapid determination of anti-heparin/platelet factor 4 antibody titers in the diagnosis of heparin-induced thrombocytopenia. Am J Med. 2003;114:528-536.
7. Zwicker JI, Uhl L, Huang WY, et al. Thrombosis and ELISA optical density values in hospitalized patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2004;2:2133-2137.
8. Haab BB, Geierstanger BH, Michailidis G, et al. Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics. 2005;5:3278-3291.
9. Marcovina S, Coppola R, Valsecchi C, et al. Monoclonal antibodies directed to the calcium-free conformation of human protein S. Thromb Haemost. 1989;62:708-714.
10. Einhauer A, Jungbauer A. Complex formation of a calcium-dependent antibody: a thermodynamical consideration. J Chromatogr A. 2003;1009:81-87.
11. Lopez JB, Peng CL. Can fluoride-oxalate and sodium citrate stabilise homocysteine levels after blood collection? Clin Chem Lab Med. 2003;41:1369-1372.
12. Bray GL, Weinmann AF, Thompson AR. Calcium-specific immunoassays for factor IX: reduced levels of antigen in patients with vitamin K disorders. J Lab Clin Med. 1986;107:269-278.
13. Visentin GP, Malik M, Cyganiak KA, et al. Patients treated with unfractionated heparin during open heart surgery are at high risk to form antibodies reactive with heparin:platelet factor 4 complexes. J Lab Clin Med. 1996;128:376-383.
14. Warkentin TE, Aird WC, Rand JH. Platelet-endothelial interactions: sepsis, HIT, and antiphospholipid syndrome. Hematology Am Soc Hematol Educ Program. 2003:497-519.
15. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310.
16. Files JC, Malpass TW, Yee EK, et al. Studies of human platelet α-granule release in vivo. Blood. 1981;58:607-618.
17. Rauova L, Poncz M, McKenzie SE, et al. Ultralarge complexes of PF4 and heparin are central to the pathogenesis of heparin-induced thrombocytopenia. Blood. 2005;105:131-138.
18. Bock PE, Luscombe M, Marshall SE, et al. The multiple complexes formed by the interaction of platelet factor 4 with heparin. Biochem J. 1980;191:769-776.
19. Warkentin TE, Kelton JG. Delayed-onset heparin-induced thrombocytopenia and thrombosis. Ann Intern Med. 2001;135:502-506.
20. Warkentin TE, Sheppard JI. Clinical sample investigation (CSI) hematology: pinpointing the precise onset of heparin-induced thrombocytopenia (HIT). J Thromb Haemost. 2007;5:636-637.